Ohio State's novel DHODH inhibitor enters first human trials
A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer …